<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27154394</PMID><DateCompleted><Year>2017</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2518</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>27</Issue><PubDate><Year>2016</Year><Month>Jun</Month><Day>08</Day></PubDate></JournalIssue><Title>Vaccine</Title><ISOAbbreviation>Vaccine</ISOAbbreviation></Journal><ArticleTitle>Impact of enterovirus and other enteric pathogens on oral polio and rotavirus vaccine performance in Bangladeshi infants.</ArticleTitle><Pagination><StartPage>3068</StartPage><EndPage>3075</EndPage><MedlinePgn>3068-3075</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vaccine.2016.04.080</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0264-410X(16)30254-7</ELocationID><Abstract><AbstractText Label="BACKGROUND">Oral polio vaccine (OPV) and rotavirus vaccine (RV) exhibit poorer performance in low-income settings compared to high-income settings. Prior studies have suggested an inhibitory effect of concurrent non-polio enterovirus (NPEV) infection, but the impact of other enteric infections has not been comprehensively evaluated.</AbstractText><AbstractText Label="METHODS">In urban Bangladesh, we tested stools for a broad range of enteric viruses, bacteria, parasites, and fungi by quantitative PCR from infants at weeks 6 and 10 of life, coincident with the first OPV and RV administration respectively, and examined the association between enteropathogen quantity and subsequent OPV serum neutralizing titers, serum rotavirus IgA, and rotavirus diarrhea.</AbstractText><AbstractText Label="RESULTS">Campylobacter and enterovirus (EV) quantity at the time of administration of the first dose of OPV was associated with lower OPV1-2 serum neutralizing titers, while enterovirus quantity was also associated with diminished rotavirus IgA (-0.08 change in log titer per tenfold increase in quantity; P=0.037), failure to seroconvert (OR 0.78, 95% CI: 0.64-0.96; P=0.022), and breakthrough rotavirus diarrhea (OR 1.34, 95% CI: 1.05-1.71; P=0.020) after adjusting for potential confounders. These associations were not observed for Sabin strain poliovirus quantity.</AbstractText><AbstractText Label="CONCLUSION">In this broad survey of enteropathogens and oral vaccine performance we find a particular association between EV carriage, particularly NPEV, and OPV immunogenicity and RV protection. Strategies to reduce EV infections may improve oral vaccine responses. ClinicalTrials.gov Identifier: NCT01375647.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Taniuchi</LastName><ForeName>Mami</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville 22908, USA. Electronic address: mt2f@virginia.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Platts-Mills</LastName><ForeName>James A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville 22908, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Begum</LastName><ForeName>Sharmin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Vaccine Science and Parasitology Lab, International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka 1212, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uddin</LastName><ForeName>Md Jashim</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Center for Vaccine Science and Parasitology Lab, International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka 1212, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sobuz</LastName><ForeName>Shihab U</ForeName><Initials>SU</Initials><AffiliationInfo><Affiliation>Center for Vaccine Science and Parasitology Lab, International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka 1212, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville 22908, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirkpatrick</LastName><ForeName>Beth D</ForeName><Initials>BD</Initials><AffiliationInfo><Affiliation>Vaccine Testing Center and Unit of Infectious Diseases, Department of Medicine, University of Vermont College of Medicine, Burlington, VT 05405, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colgate</LastName><ForeName>E Ross</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>Vaccine Testing Center and Unit of Infectious Diseases, Department of Medicine, University of Vermont College of Medicine, Burlington, VT 05405, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carmolli</LastName><ForeName>Marya P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Vaccine Testing Center and Unit of Infectious Diseases, Department of Medicine, University of Vermont College of Medicine, Burlington, VT 05405, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dickson</LastName><ForeName>Dorothy M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Vaccine Testing Center and Unit of Infectious Diseases, Department of Medicine, University of Vermont College of Medicine, Burlington, VT 05405, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nayak</LastName><ForeName>Uma</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Center for Public Health Genomics, University of Virginia, Charlottesville 22908, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haque</LastName><ForeName>Rashidul</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center for Vaccine Science and Parasitology Lab, International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka 1212, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petri</LastName><ForeName>William A</ForeName><Initials>WA</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville 22908, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Houpt</LastName><ForeName>Eric R</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville 22908, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT01375647</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>K23 AI114888</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI043596</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D017428">Clinical Trial, Phase III</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>05</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Vaccine</MedlineTA><NlmUniqueID>8406899</NlmUniqueID><ISSNLinking>0264-410X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007070">Immunoglobulin A</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C492457">RIX4414 vaccine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D022243">Rotavirus Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014613">Vaccines, Attenuated</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001459" MajorTopicYN="N">Bangladesh</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002167" MajorTopicYN="N">Campylobacter</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002169" MajorTopicYN="N">Campylobacter Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005243" MajorTopicYN="N">Feces</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007070" MajorTopicYN="N">Immunoglobulin A</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="N">Poliovirus Vaccine, Oral</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D022243" MajorTopicYN="N">Rotavirus Vaccines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014613" MajorTopicYN="N">Vaccines, Attenuated</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Enteric infections</Keyword><Keyword MajorTopicYN="N">Oral polio vaccine</Keyword><Keyword MajorTopicYN="N">PCR</Keyword><Keyword MajorTopicYN="N">Rotavirus vaccine</Keyword><Keyword MajorTopicYN="N">Vaccine efficacy</Keyword><Keyword MajorTopicYN="N">Vaccine immunogenicity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>6</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27154394</ArticleId><ArticleId IdType="pmc">PMC4912219</ArticleId><ArticleId IdType="doi">10.1016/j.vaccine.2016.04.080</ArticleId><ArticleId IdType="pii">S0264-410X(16)30254-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ogra P.L., Okayasu H., Czerkinsky C., Sutter R.W. Mucosal immunity to poliovirus. Expert Rev Vaccines. 2011;10(10):1389&#x2013;1392.</Citation><ArticleIdList><ArticleId IdType="pubmed">21988303</ArticleId></ArticleIdList></Reference><Reference><Citation>Serazin A.C., Shackelton L.A., Wilson C., Bhan M.K. Improving the performance of enteric vaccines in the developing world. Nat Immunol. 2010;11(9):769&#x2013;773.</Citation><ArticleIdList><ArticleId IdType="pubmed">20720580</ArticleId></ArticleIdList></Reference><Reference><Citation>Plotkin S.A., Lebrun A., Koprowski H. Vaccination with the CHAT strain of type 1 attenuated poliomyelitis virus in Leopoldville, Belgian Congo. 2. Studies of the safety and efficacy of vaccination. Bull World Health Organ. 1960;22:215&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2555322</ArticleId><ArticleId IdType="pubmed">14433516</ArticleId></ArticleIdList></Reference><Reference><Citation>John T.J., Jayabal P. Oral polio vaccination of children in the tropics. I. The poor seroconversion rates and the absence of viral interference. Am J Epidemiol. 1972;96(4):263&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pubmed">4342327</ArticleId></ArticleIdList></Reference><Reference><Citation>Emperador D.M., Velasquez D.E., Estivariz C.F., Lopman B., Jiang B., Parashar U. Interference of monovalent, bivalent, and trivalent oral poliovirus vaccines on monovalent rotavirus vaccine immunogenicity in rural Bangladesh. Clin Infect Dis. 2015;62:150&#x2013;156.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4755336</ArticleId><ArticleId IdType="pubmed">26349548</ArticleId></ArticleIdList></Reference><Reference><Citation>Haque R., Snider C., Liu Y., Ma J.Z., Liu L., Nayak U. Oral polio vaccine response in breast fed infants with malnutrition and diarrhea. Vaccine. 2014;32(4):478&#x2013;482.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4936916</ArticleId><ArticleId IdType="pubmed">24300591</ArticleId></ArticleIdList></Reference><Reference><Citation>Maldonado Y.A., Pena-Cruz V., de la Luz Sanchez M., Logan L., Blandon S., Cantwell M.F. Host and viral factors affecting the decreased immunogenicity of Sabin type 3 vaccine after administration of trivalent oral polio vaccine to rural Mayan children. J Infect Dis. 1997;175(3):545&#x2013;553.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7110245</ArticleId><ArticleId IdType="pubmed">9041324</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel M., Steele A.D., Parashar U.D. Influence of oral polio vaccines on performance of the monovalent and pentavalent rotavirus vaccines. Vaccine. 2012;30(Suppl. 1):A30&#x2013;A35.</Citation><ArticleIdList><ArticleId IdType="pubmed">22520134</ArticleId></ArticleIdList></Reference><Reference><Citation>Posey D.L., Linkins R.W., Oliveria M.J., Monteiro D., Patriarca P.A. The effect of diarrhea on oral poliovirus vaccine failure in Brazil. J Infect Dis. 1997;175(Suppl. 1):S258&#x2013;S263.</Citation><ArticleIdList><ArticleId IdType="pubmed">9203726</ArticleId></ArticleIdList></Reference><Reference><Citation>Triki H., Abdallah M.V., Ben Aissa R., Bouratbine A., Ben Ali Kacem M., Bouraoui S. Influence of host related factors on the antibody response to trivalent oral polio vaccine in Tunisian infants. Vaccine. 1997;15(10):1123&#x2013;1129.</Citation><ArticleIdList><ArticleId IdType="pubmed">9269056</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker E.P., Kampmann B., Kang G., Grassly N.C. Influence of enteric infections on response to oral poliovirus vaccine: a systematic review and meta-analysis. J Infect Dis. 2014;210(6):853&#x2013;864.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4136801</ArticleId><ArticleId IdType="pubmed">24688069</ArticleId></ArticleIdList></Reference><Reference><Citation>Taniuchi M., Sobuz S.U., Begum S., Platts-Mills J.A., Liu J., Yang Z. Etiology of diarrhea in Bangladeshi infants in the first year of life analyzed using molecular methods. J Infect Dis. 2013;208(11):1794&#x2013;1802.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3814844</ArticleId><ArticleId IdType="pubmed">24041797</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Gratz J., Amour C., Kibiki G., Becker S., Janaki L. A laboratory-developed TaqMan Array Card for simultaneous detection of 19 enteropathogens. J Clin Microbiol. 2013;51(2):472&#x2013;480.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3553916</ArticleId><ArticleId IdType="pubmed">23175269</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Kabir F., Manneh J., Lertsethtakam P., Begum S., Gratz J. Development and assessment of molecular diagnostic tests for 15 enteropathogens causing childhood diarrhoea: a multicentre study. Lancet Infect Dis. 2014;14(8):716&#x2013;724.</Citation><ArticleIdList><ArticleId IdType="pubmed">25022434</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkpatrick B.D., Colgate E.R., Mychaleckyj J.C., Haque R., Dickson D.M., Carmolli M.P. The Performance of Rotavirus and Oral Polio Vaccines in Developing Countries (PROVIDE) study: description of methods of an interventional study designed to explore complex biologic problems. Am J Trop Med Hyg. 2015;92(4):744&#x2013;751.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4385767</ArticleId><ArticleId IdType="pubmed">25711607</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO . 1997. Manual for the virological investigation of poliomyelitis.</Citation></Reference><Reference><Citation>Azim T., Ahmad S.M., Sefat E.K., Sarkar M.S., Unicomb L.E., De S. Immune response of children who develop persistent diarrhea following rotavirus infection. Clin Diagn Lab Immunol. 1999;6(5):690&#x2013;695.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC95756</ArticleId><ArticleId IdType="pubmed">10473519</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Kibiki G., Maro V., Maro A., Kumburu H., Swai N. Multiplex reverse transcription PCR Luminex assay for detection and quantitation of viral agents of gastroenteritis. J Clin Virol. 2011;50(4):308&#x2013;313.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3059344</ArticleId><ArticleId IdType="pubmed">21256076</ArticleId></ArticleIdList></Reference><Reference><Citation>Taniuchi M., Verweij J.J., Noor Z., Sobuz S.U., van Lieshout L., Petri W.A., Jr High throughput multiplex PCR and probe-based detection with Luminex beads for seven intestinal parasites. Am J Trop Med Hyg. 2011;84(2):332&#x2013;337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3029193</ArticleId><ArticleId IdType="pubmed">21292910</ArticleId></ArticleIdList></Reference><Reference><Citation>Jothikumar N., Cromeans T.L., Hill V.R., Lu X., Sobsey M.D., Erdman D.D. Quantitative real-time PCR assays for detection of human adenoviruses and identification of serotypes 40 and 41. Appl Environ Microbiol. 2005;71(6):3131&#x2013;3136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1151802</ArticleId><ArticleId IdType="pubmed">15933012</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Gratz J., Maro A., Kumburu H., Kibiki G., Taniuchi M. Simultaneous detection of six diarrhea-causing bacterial pathogens with an in-house PCR-luminex assay. J Clin Microbiol. 2012;50(1):98&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3256708</ArticleId><ArticleId IdType="pubmed">22075596</ArticleId></ArticleIdList></Reference><Reference><Citation>Basuni M., Muhi J., Othman N., Verweij J.J., Ahmad M., Miswan N. A pentaplex real-time polymerase chain reaction assay for detection of four species of soil-transmitted helminths. Am J Trop Med Hyg. 2011;84(2):338&#x2013;343.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3029194</ArticleId><ArticleId IdType="pubmed">21292911</ArticleId></ArticleIdList></Reference><Reference><Citation>Merino V.R., Nakano V., Liu C., Song Y., Finegold S.M., Avila-Campos M.J. Quantitative detection of enterotoxigenic Bacteroides fragilis subtypes isolated from children with and without diarrhea. J Clin Microbiol. 2011;49(1):416&#x2013;418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3020434</ArticleId><ArticleId IdType="pubmed">20980581</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill J.E., Paccagnella A., Law K., Melito P.L., Woodward D.L., Price L. Identification of Campylobacter spp. and discrimination from Helicobacter and Arcobacter spp. by direct sequencing of PCR-amplified cpn60 sequences and comparison to cpnDB, a chaperonin reference sequence database. J Med Microbiol. 2006;55(Pt 4):393&#x2013;399.</Citation><ArticleIdList><ArticleId IdType="pubmed">16533986</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadfield S.J., Robinson G., Elwin K., Chalmers R.M. Detection and differentiation of Cryptosporidium spp. in human clinical samples by use of real-time PCR. J Clin Microbiol. 2011;49(3):918&#x2013;924.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3067739</ArticleId><ArticleId IdType="pubmed">21177904</ArticleId></ArticleIdList></Reference><Reference><Citation>Verweij J.J., Laeijendecker D., Brienen E.A., van Lieshout L., Polderman A.M. Detection of Cyclospora cayetanensis in travellers returning from the tropics and subtropics using microscopy and real-time PCR. Int J Med Microbiol. 2003;293(2&#x2013;3):199&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pubmed">12868656</ArticleId></ArticleIdList></Reference><Reference><Citation>ten Hove R.J., van Lieshout L., Brienen E.A., Perez M.A., Verweij J.J. Real-time polymerase chain reaction for detection of Isospora belli in stool samples. Diagn Microbiol Infect Dis. 2008;61(3):280&#x2013;283.</Citation><ArticleIdList><ArticleId IdType="pubmed">18424043</ArticleId></ArticleIdList></Reference><Reference><Citation>Verweij J.J., Ten Hove R., Brienen E.A., van Lieshout L. Multiplex detection of Enterocytozoon bieneusi and Encephalitozoon spp. in fecal samples using real-time PCR. Diagn Microbiol Infect Dis. 2007;57(2):163&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pubmed">17020796</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberste M.S., Penaranda S., Rogers S.L., Henderson E., Nix W.A. Comparative evaluation of Taqman real-time PCR and semi-nested VP1 PCR for detection of enteroviruses in clinical specimens. J Clin Virol. 2010;49(1):73&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">20667767</ArticleId></ArticleIdList></Reference><Reference><Citation>Halse T.A., Edwards J., Cunningham P.L., Wolfgang W.J., Dumas N.B., Escuyer V.E. Combined real-time PCR and rpoB gene pyrosequencing for rapid identification of Mycobacterium tuberculosis and determination of rifampin resistance directly in clinical specimens. J Clin Microbiol. 2010;48(4):1182&#x2013;1188.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2849603</ArticleId><ArticleId IdType="pubmed">20107097</ArticleId></ArticleIdList></Reference><Reference><Citation>Kageyama T., Kojima S., Shinohara M., Uchida K., Fukushi S., Hoshino F.B. Broadly reactive and highly sensitive assay for Norwalk-like viruses based on real-time quantitative reverse transcription-PCR. J Clin Microbiol. 2003;41(4):1548&#x2013;1557.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC153860</ArticleId><ArticleId IdType="pubmed">12682144</ArticleId></ArticleIdList></Reference><Reference><Citation>Verweij J.J., Canales M., Polman K., Ziem J., Brienen E.A., Polderman A.M. Molecular diagnosis of Strongyloides stercoralis in faecal samples using real-time PCR. Trans R Soc Trop Med Hyg. 2009;103(4):342&#x2013;346.</Citation><ArticleIdList><ArticleId IdType="pubmed">19195671</ArticleId></ArticleIdList></Reference><Reference><Citation>Taniuchi M., Begum S., Uddin M.J., Platts-Mills J.A., Liu J., Kirkpatrick B.D. Kinetics of poliovirus shedding following oral vaccination as measured by quantitative reverse transcription-PCR versus culture. J Clin Microbiol. 2015;53(1):206&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4290924</ArticleId><ArticleId IdType="pubmed">25378579</ArticleId></ArticleIdList></Reference><Reference><Citation>Naylor C., Lu M., Haque R., Mondal D., Buonomo E., Nayak U. Environmental enteropathy: oral vaccine failure and growth faltering in infants in Bangladesh. EBioMedicine. 2015;2(11):1759&#x2013;1766.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4740306</ArticleId><ArticleId IdType="pubmed">26870801</ArticleId></ArticleIdList></Reference><Reference><Citation>Colgate E.R., Haque R., Dickson D.M., Caromolli M.P., Mychaleckyj J.C., Nayak U. 2016. A randomized controlled clinical trial in urban Bangladesh demonstrates a decrease in rotavirus gastroenteritis in the setting of delayed rotavirus vaccine dosing and an association with serum zinc independent of vaccination. [submitted for publication]</Citation><ArticleIdList><ArticleId IdType="pubmed">27217217</ArticleId></ArticleIdList></Reference><Reference><Citation>Platts-Mills J.A., Liu J., Gratz J., Mduma E., Amour C., Swai N. Detection of Campylobacter in stool and determination of significance by culture: enzyme immunoassay, and PCR in developing countries. J Clin Microbiol. 2014;52(4):1074&#x2013;1080.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3993515</ArticleId><ArticleId IdType="pubmed">24452175</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaman K., Sack D.A., Yunus M., Arifeen S.E., Podder G., Azim T. Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age. Vaccine. 2009;27(9):1333&#x2013;1339.</Citation><ArticleIdList><ArticleId IdType="pubmed">19162114</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Moon S., Wang Y., Jiang B. Multiple virus infection alters rotavirus replication and expression of cytokines and Toll-like receptors in intestinal epithelial cells. Virus Res. 2012;167(1):48&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">22497974</ArticleId></ArticleIdList></Reference><Reference><Citation>Tregnaghi M.W., Abate H.J., Valencia A., Lopez P., Da Silveira T.R., Rivera L. Human rotavirus vaccine is highly efficacious when coadministered with routine expanded program of immunization vaccines including oral poliovirus vaccine in Latin America. Pediatr Infect Dis J. 2011;30(6):e103&#x2013;e108.</Citation><ArticleIdList><ArticleId IdType="pubmed">21378594</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan F., Yang T., Ma H., Jin Y., Song S., Fontaine R.E. Risk factors for hand: foot, and mouth disease and herpangina and the preventive effect of hand-washing. Pediatrics. 2011;127(4):e898&#x2013;e904.</Citation><ArticleIdList><ArticleId IdType="pubmed">21422083</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>